HDIM
HOLX

Hanson & Doremus Investment Management’s Hologic HOLX Stock Holding History

Hanson & Doremus Investment Management’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-900
Closed -$68K – 498
2026
Q1 		$68K Hold
900
– – 0.01% 302
2025
Q4 		$67K Hold
900
– – 0.01% 296
2025
Q3 		$61K Hold
900
– – 0.01% 306
2025
Q2 		$59K Sell
900
-700
-44% -$42K 0.01% 309
2025
Q1 		$99K Buy
+1,600
New +$106K 0.01% 259
2018
Q1 		– Sell
-400
Closed -$17K – 511
2017
Q4 		$17K Hold
400
– – 0.01% 399
2017
Q3 		$15K Hold
400
– – 0.01% 394
2017
Q2 		$18K Hold
400
– – 0.01% 380
2017
Q1 		$17K Hold
400
– – 0.01% 367
2016
Q4 		$16K Hold
400
– – 0.01% 351
2016
Q3 		$16K Hold
400
– – 0.01% 339
2016
Q2 		$14K Hold
400
– – 0.01% 336
2016
Q1 		$14K Hold
400
– – 0.01% 353
2015
Q4 		$15K Buy
+400
New +$15.6K 0.01% 358

Other funds holding HOLX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Hanson & Doremus Investment Management's HOLX Position: Q2 2026 in Review

Hanson & Doremus Investment Management sold out of Hologic (HOLX) in Q2 2026, closing a stake of 900 shares — an estimated $68K sold.

Hanson & Doremus Investment Management first reported a position in HOLX in Q4 2015 and held it in 14 quarters. The position peaked at $99K in Q1 2025. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Hanson & Doremus Investment Management reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Hanson & Doremus Investment Management sold 900 Hologic shares in Q2 2026, an estimated $68K.
  • Hanson & Doremus Investment Management first reported a position in Hologic in Q4 2015 and held it in 14 quarters.
  • Hanson & Doremus Investment Management's Hologic position peaked at $99K in Q1 2025.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Hanson & Doremus Investment Management's 13F filing for Q2 2026, filed 29 Jul 2026.